Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
Rheumatology (Oxford). 2024 Sep 1;63(9):2494-2502. doi: 10.1093/rheumatology/keae216.
Substantial proportions of patients with SLE report poor health-related quality of life (HRQoL). Our objective was to investigate the impact of neuropsychiatric involvement (NP) in SLE on patient-reported outcomes.
We analysed data from four phase III trials (BLISS-52, BLISS-76, BLISS-SC, EMBRACE; N = 2968). The NPSLE group comprised individuals with NP-BILAG A/B/C/D or score in any descriptor of the NP-SLEDAI-2K at baseline (N = 350), while the non-NPSLE group consisted of patients with NP-BILAG E (N = 2618). HRQoL was assessed with the SF-36, EQ-5D-3L, and FACIT-F. Full health state (FHS) was defined as 'no problems' in all EQ-5D dimensions.
NPSLE patients reported lower scores in the SF-36 physical and mental component summary compared with the non-NPSLE population [mean (s.d.): 35.7 (9.1) vs 39.6 (9.6); P < 0.001 and 37.3 (12.1) vs 41.4 (11.0); P < 0.001, respectively]. NPSLE patients also exhibited impaired HRQoL in all EQ-5D dimensions compared with non-NPSLE patients (P < 0.05 for all). A substantially lower proportion of NPSLE patients experienced FHS in comparison with the non-NPSLE group (3.3% vs 14.5%; P < 0.001). NPSLE was associated with severe fatigue [23.8 (12.2) vs 31.5 (11.6); P < 0.001]. Notably, our findings revealed no discernible distinctions between active and inactive NPSLE patients with regard to SF-36, EQ-5D, FHS or FACIT-F scores.
NP in patients with SLE has a detrimental effect on HRQoL experience and is associated with severe fatigue, regardless of the degree of neuropsychiatric disease activity. Early intervention is warranted in NPSLE patients to enhance long-term HRQoL experience.
相当比例的系统性红斑狼疮(SLE)患者报告其健康相关生活质量(HRQoL)较差。我们的目的是调查神经精神性系统性红斑狼疮(NPSLE)对患者报告结局的影响。
我们分析了四项 III 期试验(BLISS-52、BLISS-76、BLISS-SC、EMBRACE;N=2968)的数据。NPSLE 组包含基线时存在 NP-BILAG A/B/C/D 或 NP-SLEDAI-2K 任何描述符评分的个体(N=350),而非 NPSLE 组则由 NP-BILAG E 的患者组成(N=2618)。使用 SF-36、EQ-5D-3L 和 FACIT-F 评估 HRQoL。完全健康状态(FHS)定义为所有 EQ-5D 维度均“无问题”。
与非 NPSLE 人群相比,NPSLE 患者的 SF-36 生理和心理成分综合评分较低[平均值(标准差):35.7(9.1)比 39.6(9.6);P<0.001 和 37.3(12.1)比 41.4(11.0);P<0.001]。与非 NPSLE 患者相比,NPSLE 患者在所有 EQ-5D 维度中也表现出较差的 HRQoL(所有 P<0.05)。与非 NPSLE 组相比,NPSLE 患者经历 FHS 的比例明显较低(3.3%比 14.5%;P<0.001)。NPSLE 与严重疲劳相关[23.8(12.2)比 31.5(11.6);P<0.001]。值得注意的是,我们的研究结果表明,在 SF-36、EQ-5D、FHS 或 FACIT-F 评分方面,活动期和非活动期 NPSLE 患者之间没有明显区别。
SLE 患者的 NP 对 HRQoL 体验有不利影响,并与严重疲劳有关,而与神经精神疾病活动程度无关。需要对 NPSLE 患者进行早期干预,以提高其长期 HRQoL 体验。